Save the date! May 15 – Perspective Therapeutics to provide recent business highlights and report 1Q financial results: https://lnkd.in/ewdpdeJD
Perspective Therapeutics’ Post
More Relevant Posts
-
While the field of Digital Therapeutics (DTx) brings us the promise of revolutionizing healthcare, it comes with a fair share of caveats and challenges. The story of Pear Therapeutics, a software-based digital therapeutics company from Boston, USA, serves as a prime example to illustrate this case and learnings about the DTx industry. This comprehensive infographic report by Healthark Insights captures the story in 4 phases: 1. Trailblazing Entry 2. Products Partnerships & Funding Frenzy 3. Moment of Epiphany & Downsizing 4. Downfall & Lessons Read on to know more and let us know what you think in the comments below! #digitaltherapeutics #healthandwellness #digitalhealth #digitalization
To view or add a comment, sign in
-
1 week left to register for a free webinar on "Navigating the New Era of Asset Maintenance Management: 4D Molecular Therapeutics’ Transformation". https://lnkd.in/gHFh-dG8 . Attendees will learn how 4D Molecular Therapeutics overhauled their manual maintenance-related processes throughout their facility, unveiling a plethora of improvement opportunities. Dave Porrill from Blue Mountain and Wes Champion from PCI will discuss 4DMT’s journey of implementing a validated Computerized Maintenance Management System (CMMS) and the tangible benefits they reaped. It not only brought about better alignment and structure to their processes, but it also revolutionized their maintenance workflow. Register here to attend: https://lnkd.in/gHFh-dG8 . #BlueMountainRAM #GMPDigitalMaturtityModel #RegulatoryAssetManager #AdvanceGMPcompliance
To view or add a comment, sign in
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> Moderna partners with Blackstone on flu shots, nabbing up to $750M in R&D funding >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #productmarketing #pharma #pharmaceutical #healthcare
Moderna partners with Blackstone on flu shots, nabbing up to $750M in R&D funding
https://endpts.com
To view or add a comment, sign in
-
The life sciences industry is a network of stakeholders, all of whom play a vital role in bringing therapeutics and #diagnostics to patients. Now several trends are impacting this ecosystem. Here are five of them, along with their implications for life sciences companies and investors. https://bit.ly/44PFWpo #lifesciences
Navigating the Shifting Landscape in Life Sciences: Trends and Implications | L.E.K. Consulting
lek.com
To view or add a comment, sign in
-
Thoughts on this? >> Moderna partners with Blackstone on flu shots, nabbing up to $750M in R&D funding >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #pharmaceutical #pharma #productmarketing #healthcare
Moderna partners with Blackstone on flu shots, nabbing up to $750M in R&D funding
https://endpts.com
To view or add a comment, sign in
-
Director | C-Level | Collaborative Leader | Team Builder | Diversity & Inclusion | Marketing | Strategy | Innovation | Commercialization | Global Pharmaceuticals
The life sciences industry is a network of stakeholders, all of whom play a vital role in bringing therapeutics and #diagnostics to patients. Now several trends are impacting this ecosystem. Here are five of them, along with their implications for life sciences companies and investors. https://bit.ly/44PFWpo #lifesciences #LEKconsulting #healthcareinnovation #healthcaretrends
The life sciences industry is a network of stakeholders, all of whom play a vital role in bringing therapeutics and #diagnostics to patients. Now several trends are impacting this ecosystem. Here are five of them, along with their implications for life sciences companies and investors. https://bit.ly/44PFWpo #lifesciences
Navigating the Shifting Landscape in Life Sciences: Trends and Implications | L.E.K. Consulting
lek.com
To view or add a comment, sign in
-
Compound management is an important and vital part of any organization focused on the development of small molecules for therapeutic use. Gina Prophete, manager of sample management at Accent Therapeutics, Inc. took us through understanding the importance of selecting the right equipment, software, and personnel for compound management workflows for each stage of the company’s growth, while simultaneously planning for future improvements of a small compound management lab. Watch the full webinar - https://bit.ly/3K2s2aR #compoundmanagement
To view or add a comment, sign in
-
Don't forget to register for our (free) webinar this Thursday, Oct. 19 (11am ET, 5pm CET): "Creating High Value Biotechs: The Tier Jumpers" Register: https://lnkd.in/gCp9z68F (If you can't join live, register instead to watch the on-demand recording.) Speakers include my BioCentury Inc. colleague Simone Fishburn, Michael Margolis of Oppenheimer & Co. Inc., Jami Rubin of Boundless Bio, Rachel Mears of JEITO, Joep Muijrers of Gilde Healthcare and Dinesh V. Patel of Protagonist Therapeutics. Topics include: ➣ What are the keys to building sustainable high-value biotechs? ➣ What is required for biotechs to jump market cap tier? ➣ How do you pick your lead asset? ➣ When is the right time to partner? ➣ How do you optimize around probability of success? ➣ And much more... The live webinar includes Q&A. We hope to see you there! #biotech #biopharma #pharma #venturecapital
To view or add a comment, sign in
-
The life sciences industry is a network of stakeholders, all of whom play a vital role in bringing therapeutics and #diagnostics to patients. Now several trends are impacting this ecosystem. Here are five of them, along with their implications for life sciences companies and investors. https://bit.ly/44PFWpo #lifesciences
Navigating the Shifting Landscape in Life Sciences: Trends and Implications | L.E.K. Consulting
lek.com
To view or add a comment, sign in
6,043 followers